image description

Tag: Arthritis Research & Therapy

Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis

April 1, 2020 An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus nephritis that is refractory, meaning it has stubbornly resisted previous treatment with at least two immunosuppressants. Results were reported in Arthritis Research & Therapy. The small study included 14 patients with refractory lupus nephritis. Each were […] Read More

Living in a Disadvantaged Neighborhood Lowers Follow-up Care

March 4, 2020 A new study showed that living in a disadvantaged neighborhood predicts poor retention (follow-up) care for people with lupus.  Retention was defined specifically has having two out-patient doctor visits or lab tests such as measuring complement levels. Researchers looked at the records of 397 patients with lupus in terms of age, sex, […] Read More

LRA-Funded Researcher Finds New Biomarkers for Lupus Nephritis

August 7, 2019 Dr. Chandra Mohan discovered that blood clotting proteins are higher in the urine of people with lupus nephritis, announced University of Houston. His work showed that both proteins that promote clotting and those that work to dissolve them are involved.  He began examining these proteins because people with lupus and lupus nephritis […] Read More

Association Between Lupus and Cancer

January 4, 2019 A new analysis published in Arthritis Research & Therapy found that SLE is associated with increased risk of 16 cancers and decreased risk for prostate cancer and cutaneous (skin) melanoma.  The analysis included data from 24 published studies.  Increased risk was seen in non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, leukemia, multiple myeloma, cervix, vagina/vulva, renal, […] Read More
Stay informed about events, research developments, and ways you can help. Sign up for updates